Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-16 3:36 pm Purchase | 2020-12-31 | 13G | Albireo Pharma, Inc. ALBO | PERCEPTIVE ADVISORS LLC | 2,360,139 12.400% | 655,809 (+38.48%) | Filing History |
| 2021-02-16 1:29 pm Sale | 2020-12-31 | 13G | Albireo Pharma, Inc. ALBO | ArrowMark Colorado Holdings LLC | 751,495 3.900% | -115,555 (-13.33%) | Filing History |
| 2021-02-12 1:16 pm Purchase | 2020-12-31 | 13G | Albireo Pharma, Inc. ALBO | FEDERATED HERMES INC. FHI | 2,447,000 12.830% | 1,010,000 (+70.29%) | Filing History |
| 2021-02-12 07:01 am Sale | 2020-12-31 | 13G | Albireo Pharma, Inc. ALBO | Satter Muneer A | 0 0.000% | -832,000 (Position Closed) | Filing History |
| 2021-02-02 3:13 pm Purchase | 2020-12-31 | 13G | Albireo Pharma, Inc. ALBO | BLACKROCK INC BLK | 1,242,780 6.500% | 556,324 (+81.04%) | Filing History |
| 2020-10-23 5:05 pm Sale | 2019-11-06 | 13D | Albireo Pharma, Inc. ALBO | TVM Life Science Ventures VI LP | 0 0.000% | -621,761 (Position Closed) | Filing History |